| Trial ID: | L1624 |
| Source ID: | NCT00277693
|
| Associated Drug: |
Spironolactone (Drug)
|
| Title: |
Cardiovascular Protective Effect of Spironolactone in Hemodialysis
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hemodialysis
|
| Interventions: |
DRUG: Spironolactone (drug)
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Universidad de los Andes, Chile
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-01-16
|
| Locations: |
Clinica Davila, Santiago, Chile
|
| URL: |
https://clinicaltrials.gov/show/NCT00277693
|
